Facebook
Twitter
LinkedIn
Forward
This session explores the use of anti-obesity medications through complex case-based scenarios, providing a hands-on approach to understanding their application in real-world situations.
|
This presentation explores emerging investigational therapies designed to combat obesity.
|
Take your advocacy skills to the next level with this in-depth panel discussion featuring seasoned experts sharing lessons from the field.
|
Does managing obesity in children and teens feel overwhelming?
|
Stress and obesity are connected through multiple interacting pathways that span cognition, behavior, physiology, and biochemistry, including the eight major chemicals that drive overeating and wei
|
This presentation is designed for obesity medicine providers to build practical skills and advance their knowledge in nutrition assessment and evaluation of the metabolic and bariatric surgery (MBS
|
This session will explore the latest advancements in obesity phenotyping, a cutting-edge approach pioneered at Mayo Clinic, and its practical implementation in clinical settings.
|
Rising obesity rates are driving an epidemic of obesity-related OSA while access to care from a sleep specialist is limited.
|
Obesity is a heterogeneous, complex, chronic, and progressive disease. It is essential that clinicians recognize that a patient’s disease response to treatment can vary significantly.
|
The rise in the use of glucagon-like peptide 1 receptor agonists (GLP-1RA) for weight loss has generated significant interest due to their efficacy in reducing body weight.
|